Recent Finacing
Recent Raise
Ovid Therapeutics, based in New York, develops therapies for rare neurological disorders, advancing OV101 for Angelman and Fragile X syndromes and internal compounds toward clinical testing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
